Partner Content Partner Content Exclusive Sanofi R&D speaker interview released for 5th Lyop... Lyophilization USA Update
Partner Content Partner Content Lyophilisation explained in its most simplistic terms SMi reports: There are two post-conference workshops taking place on the 5th June 2019, which will explain lyophilisation in its most simplistic terms.
Partner Content Partner Content Spotlight sessions at the upcoming Lyophilization USA Confer... Lyophilization USA Conference
Partner Content Partner Content Achieving Controlled Nucleation During Aseptic Lyophilizatio... 4th Annual Lyophilization USA Conference
Partner Content Partner Content SMi’s exclusive speaker interview with Abon Pharmaceuticals,... SMi Reports: An exclusive interview with Dr.
News Roche places a $1bn bet on C4T degrader-antibody conjugates Roche is paying $20 million upfront to secure rights to two degrader-antibody conjugates (DACs) for cancer developed by longtime partner C4T.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
